These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7192425)

  • 1. Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trial.
    Hayat M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Guerrin J; Misset JL; Pommatau E; Ribaud P; Muggia FM; Rozencweig M; Mathé G
    Recent Results Cancer Res; 1980; 74():139-45. PubMed ID: 7192425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
    Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
    Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma.
    Brenner J; Magill GB; Sordillo PP; Cheng EW; Yagoda A
    Cancer; 1982 Nov; 50(10):2031-3. PubMed ID: 6889911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
    Pratt CB; Hayes A; Green AA; Evans WE; Senzer N; Howarth CB; Ransom JL; Crom W
    Cancer Treat Rep; 1981; 65(11-12):1021-6. PubMed ID: 7197583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.
    Hayes DM; Cvitkovic E; Golbey RB; Scheiner E; Helson L; Krakoff IH
    Cancer; 1977 Apr; 39(4):1372-81. PubMed ID: 856437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy.
    Reichman B; Markman M; Hakes T; Budnick A; Rubin S; Jones W; Almadrones L; Lewis JL; Hoskins W
    Gynecol Oncol; 1991 Nov; 43(2):159-63. PubMed ID: 1743559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
    Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
    Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
    Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P
    Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin.
    Motzer RJ; Bosl GJ; Tauer K; Golbey R
    Cancer Treat Rep; 1987 Feb; 71(2):197-8. PubMed ID: 3026627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II trial with cisplatin in ovarian malignancies].
    Hosokawa T; Ito H; Tanaka T; Ichinoe K; Yamada Y; Suzuki M; Yajima A; Mori T; Takamizawa H; Sekiya S; Sakamoto S; Kawana T; Chen JT; Takada M; Takeuchi H; Akiya K; Hara S; Hara Y; Takeuchi S; Kanazawa K; Yoshizawa H; Tomoda Y; Ohta M; Hattori S; Yagami Y; Mizuno K; Koike K; Suzuoki Y; Totani R; Miwa T; Sugimoto O; Fujimoto A; Doi S; Tojo S; Iwasaki M; Sekiba K; Kohno I; Okazaki H; Ogawa S; Seto M; Komoto Y; Taki I; Tsukamoto N; Iwasaka T; Yamabe T; Nakajima H; Yoshida M
    Nihon Gan Chiryo Gakkai Shi; 1982 Feb; 17(1):31-40. PubMed ID: 6890088
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I and II agents in cancer therapy: two cisplatin analogues and high-dose cisplatin in hypertonic saline or with thiosulfate protection.
    Fuks JZ; Wadler S; Wiernik PH
    J Clin Pharmacol; 1987; 27(5):357-65. PubMed ID: 3320104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies.
    Gonzalez-Vitale JC; Hayes DM; Cvitkovic E; Sternberg SS
    Cancer Treat Rep; 1978 May; 62(5):693-8. PubMed ID: 657154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients.
    Frustaci S; Barzan L; Tumolo S; Comoretto R; Quadu G; Galligioni E; Lorenzini M; Crivellari D; Caruso G; Piccinin G
    Cancer; 1986 Mar; 57(6):1118-23. PubMed ID: 3943035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study.
    Sexauer CL; Khan A; Burger PC; Krischer JP; van Eys J; Vats T; Ragab AH
    Cancer; 1985 Oct; 56(7):1497-501. PubMed ID: 4040799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study.
    Nitschke R; Fagundo R; Berry DH; Falletta JM
    Cancer Treat Rep; 1979 Mar; 63(3):497-9. PubMed ID: 427829
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors.
    Fury MG; Sherman E; Haque S; Korte S; Lisa D; Shen R; Wu N; Pfister D
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):591-8. PubMed ID: 21913034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin (platidiam) and the prospects for using complex platinum compounds in the clinical chemotherapy of malignant tumors].
    Gorbunova VA
    Vopr Onkol; 1989; 35(3):325-30. PubMed ID: 2705315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.